EE03492B1 - Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid - Google Patents

Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid

Info

Publication number
EE03492B1
EE03492B1 EE9700040A EE9700040A EE03492B1 EE 03492 B1 EE03492 B1 EE 03492B1 EE 9700040 A EE9700040 A EE 9700040A EE 9700040 A EE9700040 A EE 9700040A EE 03492 B1 EE03492 B1 EE 03492B1
Authority
EE
Estonia
Prior art keywords
region
auto
retroviral vectors
direct expression
inactivating retroviral
Prior art date
Application number
EE9700040A
Other languages
English (en)
Estonian (et)
Other versions
EE9700040A (et
Inventor
Henry G�nzburg Walter
Michael Saller Robert
Original Assignee
GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH filed Critical GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH
Publication of EE9700040A publication Critical patent/EE9700040A/xx
Publication of EE03492B1 publication Critical patent/EE03492B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ceramic Products (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Electrotherapy Devices (AREA)
EE9700040A 1994-09-02 1995-09-01 Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid EE03492B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (2)

Publication Number Publication Date
EE9700040A EE9700040A (et) 1997-08-15
EE03492B1 true EE03492B1 (et) 2001-08-15

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700040A EE03492B1 (et) 1994-09-02 1995-09-01 Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid

Country Status (20)

Country Link
US (1) US7531353B1 (pl)
EP (1) EP0779929B1 (pl)
JP (1) JP4037446B2 (pl)
CN (1) CN1117156C (pl)
AT (1) ATE200517T1 (pl)
AU (1) AU688590B2 (pl)
BR (1) BR9508664A (pl)
CA (1) CA2198210C (pl)
DE (1) DE69520681T2 (pl)
DK (1) DK0779929T5 (pl)
EE (1) EE03492B1 (pl)
ES (1) ES2156945T3 (pl)
FI (1) FI970892L (pl)
HU (1) HU221607B (pl)
MX (1) MX9701544A (pl)
NO (1) NO317731B1 (pl)
NZ (1) NZ292897A (pl)
PL (1) PL184375B1 (pl)
RU (1) RU2199585C2 (pl)
WO (1) WO1996007748A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69520681T2 (de) 1994-09-02 2001-11-29 Gsf - Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
ES2198479T3 (es) * 1995-03-09 2004-02-01 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Vectores que llevan genes terapeuticos codificantes de peptidos antimicrobianos para terapia genica.
WO1997001357A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
ATE217023T1 (de) * 1995-10-13 2002-05-15 Austrian Nordic Biotherapeutic Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
DK0892852T3 (da) 1996-03-27 2006-03-06 Bavarian Nordic Res Inst As Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
WO1998032869A1 (en) * 1997-01-29 1998-07-30 Neurosearch A/S Expression vectors and methods for in vivo expression of therapeutic polypeptides
PT1895010E (pt) * 1997-12-22 2012-01-25 Oxford Biomedica Ltd Vectores com base no vírus da anemia infecciosa equina (eiav)
DE69920659T2 (de) * 1998-01-06 2006-03-09 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
WO2000066758A1 (en) * 1999-04-29 2000-11-09 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem
CN120866241B (zh) * 2025-09-28 2026-01-30 深圳细胞谷生物医药有限公司 通过稳定细胞系生产工程化类病毒颗粒的方法及其工程化类病毒颗粒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371119B1 (en) 1988-05-17 1996-09-04 Sloan-Kettering Institute For Cancer Research Retroviral vector
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
DE69520681T2 (de) 1994-09-02 2001-11-29 Gsf - Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
ES2198479T3 (es) * 1995-03-09 2004-02-01 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Vectores que llevan genes terapeuticos codificantes de peptidos antimicrobianos para terapia genica.
EP1162273A1 (en) * 1995-03-09 2001-12-12 Austrian Nordic Biotherapeutics AG Recombinant DNA vectors for gene therapy
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
NO970902D0 (no) 1997-02-27
ES2156945T3 (es) 2001-08-01
FI970892A7 (fi) 1997-02-28
NO317731B1 (no) 2004-12-13
CN1159210A (zh) 1997-09-10
DK0779929T3 (da) 2001-05-07
AU688590B2 (en) 1998-03-12
DE69520681D1 (de) 2001-05-17
EP0779929B1 (en) 2001-04-11
MX9701544A (es) 1998-03-31
EP0779929A1 (en) 1997-06-25
DK0779929T5 (da) 2001-08-13
PL319033A1 (en) 1997-07-21
HU221607B (hu) 2002-11-28
FI970892A0 (fi) 1997-02-28
RU2199585C2 (ru) 2003-02-27
HK1001527A1 (en) 1998-06-26
US7531353B1 (en) 2009-05-12
CA2198210A1 (en) 1996-03-14
AU3520195A (en) 1996-03-27
EE9700040A (et) 1997-08-15
JPH10507628A (ja) 1998-07-28
ATE200517T1 (de) 2001-04-15
PL184375B1 (pl) 2002-10-31
JP4037446B2 (ja) 2008-01-23
DE69520681T2 (de) 2001-11-29
BR9508664A (pt) 1998-01-06
NZ292897A (en) 1998-08-26
HUT76974A (hu) 1998-01-28
FI970892L (fi) 1997-02-28
NO970902L (no) 1997-04-24
WO1996007748A1 (en) 1996-03-14
CA2198210C (en) 2006-07-11
CN1117156C (zh) 2003-08-06

Similar Documents

Publication Publication Date Title
EE03492B1 (et) Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid
WO1998039463A3 (en) Lentivirus based vector and vector system
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ATE211764T1 (de) Conotoxinpeptide
NO953462D0 (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
EE04378B1 (xx) LAG-3 pleissimisteisendid
DE69233785D1 (de) diert
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
CA2267945A1 (en) Anticonvulsant derivatives useful in treating neuropathic pain
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ATE173762T1 (de) Klonierung der n-methylhydantoinase
DE69321235D1 (de) Promoter vom k. lactis pyruvat-decarboxylase gen und anwendung davon
ATE89005T1 (de) Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
MX9605731A (es) Preparacion de un catalizador de hidratacion con empleo de m(or)mxn.
MY116724A (en) Ethylene polymerization process in the presence of a chromium oxide catalyst
ES8505684A1 (es) Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas
DE69427827D1 (de) Verfahren zur Herstellung von Sulfonylharnstoffderivaten und Zwischenprodukte für dieses Verfahren
UA20042A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhо-ізо-фталімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
MX9707249A (es) Catalizador y proceso para la hidrogenacion de olefinas o polimeros.
MX9701638A (es) Oxidos de alquilfenilbisacilfosfina y mezclas de fotoiniciador.
DE69729098D1 (de) Fluorierung von ketoamiden

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110901